Edgewise Therapeutics, Inc. (EWTX) stock

EWTXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30

$45.93+0.11 (+0.24%)

Close on Nov 13, 2026Market cap $4.99BP/E 5.6Yield –

Edgewise Therapeutics statistics

67 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 25, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $4.99B; $272.32M
Enterprise Value: $4.92B; $146.23M
PE Ratio: 5.61; 25.11
PB Ratio: 3.06; 2.00
P/TBV Ratio: 3.06; 2.22

Share statisticsIndustry

Shares Outstanding: 109M; 58M
Shares Change (YoY): 10.3%; 10.8%
Shares Change (QoQ): 1.56%; 0.50%
Float: 87M; 49M
Shares Held by Insiders: 20.0%; 11.7%
Shares Held by Institutions: 109.7%; 56.4%

Short sellingIndustry

Short Interest: 13M; –
Short Interest Change: 8.04%; -0.80%
Short % of Float: 14.6%; 9.01%
Short % of Shares Outstanding: 11.7%; 6.30%
Days to Cover: 9.64; 5.15

Stock price statisticsIndustry

52-Week High: $48.78; –
52-Week Low: $19.76; –
20-Day Moving Average: $41.27; –
50-Day Moving Average: $41.33; –
200-Day Moving Average: $37.01; –
Average True Range (14): $2.85; –
Price Change (1 Week): 1.98%; -1.15%
Price Change (1 Month): 20.2%; -4.87%
Price Change (3 Months): 4.29%; -21.0%
Price Change (6 Months): 38.8%; -20.6%
Price Change (YTD): 85.1%; -23.6%
Price Change (1 Year): 117.0%; -22.4%
Price Change (3 Years): 605.5%; -29.5%
Price Change (5 Years): 139.1%; -77.9%
Average Volume (10 Days): 2M; –
Average Volume (20 Days): 2M; –
Average Volume (90 Days): 1M; –
Relative Volume: 0.81; 0.70
Relative Strength Index (14): 61.8; 43.4
Volatility (1 Year): 73.2%; 80.1%
Beta (5 Years): 1.47; 1.07

Returns on capitalIndustry

Return on Equity (ROE): 92.1%; -49.9%
Return on Assets (ROA): 85.4%; -40.6%
Return on Invested Capital (ROIC): -16.6%; -32.9%
Return on Capital Employed (ROCE): -13.3%; -37.9%

Financial positionIndustry

Current Ratio: 12.30; 3.30
Quick Ratio: 0.48; 2.39

EfficiencyIndustry

Profits Per Employee: $6.92M; -$689.41K
Employee Count: 146; 74
WACC: 12.5%; 10.2%

Income statement (TTM)Industry

Operating Income: -$218.18M; -$21.37M
Net Income: $1.01B; -$22.35M
EBITDA: -$218.18M; -$17.21M
EPS (Diluted): $8.19; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $68.68M; $68.68M
Net Cash (Debt): $68.68M; $17.76M
Net Cash Per Share: $0.63; $0.80
Equity (Book Value): $1.63B; $53.89M
Book Value Per Share: $15.03; $1.50
Tangible Book Value: $1.63B; $27.13M
Working Capital: $1.63B; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$201.90M; -$12.38M
Capital Expenditures: -$382.00K; -$1.00M
Free Cash Flow: -$202.28M; -$18.21M
FCF Per Share: -$1.86; -$0.42

Dividends and yieldsIndustry

Earnings Yield: 20.2%; -21.8%
FCF Yield: -4.06%; -9.44%

Scores and fair valueIndustry

Graham Number: $52.63; $19.34
Graham Upside: 14.6%; -46.6%
Altman Z-Score: 21.41; 0.23
Piotroski F-Score: 3; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	EWTX	S&P 500	Difference	EWTX per year	S&P 500 per year
1 month	+26.6%	-3.0%	+29.6 pts
3 months	+6.4%	-2.8%	+9.2 pts
Year to date	+85.1%	+11.5%	+73.6 pts
1 year	+124.9%	+13.5%	+111.5 pts
3 years	+649.3%	+77.7%	+571.6 pts	+95.7%	+21.1%
5 years	+139.1%	+72.6%	+66.5 pts	+19.0%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

13M EWTX shares were sold short on Oct 30, 2026, up 8.0% from the previous report, or 14.62% of the shares available to trade. At recent volumes it would take 9.6 days to buy them back. Over the last 20 sessions, 58.9% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	12,696,203	+8.0%	1,316,851	9.6
Oct 15, 2026	11,751,785	+4.7%	1,385,615	8.5
Sep 30, 2026	11,224,347	+17.6%	2,003,524	5.6
Sep 15, 2026	9,543,843	+2.1%	1,188,397	8.0
Aug 31, 2026	9,346,141	-3.4%	1,164,287	8.0
Aug 14, 2026	9,675,389	-1.6%	1,513,577	6.4
Jul 31, 2026	9,835,054	-2.4%	815,024	12.1
Jul 15, 2026	10,074,332	-4.0%	1,211,852	8.3
Jun 30, 2026	10,492,798	+5.7%	2,083,624	5.0
Jun 15, 2026	9,931,057	-9.0%	1,739,288	5.7
May 29, 2026	10,911,621	+5.4%	982,747	11.1
May 15, 2026	10,353,369	+2.2%	1,483,537	7.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?